Finasteride and Blushing - a phase IV clinical study of FDA data

Summary:

Blushing is reported as a side effect among people who take Finasteride (finasteride), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Niaspan, and have High blood cholesterol.

The phase IV clinical study analyzes which people have Blushing when taking Finasteride. It is created by eHealthMe based on reports of 42,469 people who have side effects when taking Finasteride from the FDA, and is updated regularly.

What is Finasteride?

Finasteride has active ingredients of finasteride. It is often used in prostate examination abnormal. eHealthMe is studying from 44,160 Finasteride users. Check the latest studies of Finasteride.

What is Blushing?

Blushing is found to be associated with 3,333 drugs and 2,894 conditions by eHealthMe. Check the latest studies of Blushing.

On Nov, 11, 2025

42,469 people reported to have side effects when taking Finasteride.
Among them, 224 people (0.53%) have Blushing.

Among these 224 people:

How long have people been on Finasteride when they have Blushing? *

What is the gender of people who have Blushing when taking Finasteride? *

female: 3.26 %
male: 96.74 %

What is the age of people who have Blushing when taking Finasteride? *

What are other drugs people take besides Finasteride? *

What are other side effects people have besides Blushing? *

Stress And Anxiety: 49 people, 21.88%
Dizziness: 44 people, 19.64%
Fatigue (feeling of tiredness): 41 people, 18.30%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 36 people, 16.07%
Rashes (redness): 33 people, 14.73%
Back Pain: 31 people, 13.84%
Itching: 30 people, 13.39%
Nausea (feeling of having an urge to vomit): 29 people, 12.95%
Headache (pain in head): 28 people, 12.50%
High Blood Pressure: 26 people, 11.61%

What are the existing conditions these people have? *

High Blood Cholesterol: 34 people, 15.18%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 33 people, 14.73%
High Density Lipoprotein Decreased: 21 people, 9.38%
Androgenetic Alopecia (common form of hair loss): 17 people, 7.59%
High Blood Pressure: 14 people, 6.25%
Hyperlipidaemia (presence of excess lipids in the blood): 11 people, 4.91%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 11 people, 4.91%
Prostatomegaly (enlargement of the prostate): 8 people, 3.57%
Gait Disturbance: 8 people, 3.57%
Prostatic Disorder: 8 people, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Finasteride and have Blushing?

- Check whether Blushing is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Finasteride:

Finasteride (44,160 reports)

Blushing treatments and more:

Blushing (117,674 reports)

Browse all side effects of Finasteride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common drugs associated with Blushing:

Browse all the drugs that are associated with Blushing:

Blushing (3,333 drugs)

Common conditions associated with Blushing:

Ms hug: 22,392 reports
High blood cholesterol: 11,125 reports
Lipoprotein test: 11,039 reports
Reduce cholesterol: 10,836 reports
Lipid profile: 10,700 reports
Lower cholesterol: 10,648 reports
Primary pulmonary hypertension: 6,234 reports
High density lipoprotein decreased: 4,574 reports
Hypertension: 3,292 reports
Blood pressure - high: 3,262 reports

Browse all the conditions that are associated with Blushing:

Blushing (2,894 conditions)

Drugs similar to Finasteride and Blushing :

Related publications that referenced our studies

Fouda AM, Bazeed AM, "Hematuria and Hematospermia Associated with the Use of Finasteride for the Treatment of Androgenic Alopecia: A Case Report", Drug Safety-Case Reports, 2017 Dec .
Fouda AM, Bazeed AM, "Hematuria and Hematospermia Associated with the Use of Finasteride for the Treatment of Androgenic Alopecia: A Case Report", Drug Safety-Case Reports, 2017 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on finasteride (the active ingredients of Finasteride) and Finasteride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.